BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:11 PM
 | 
Jun 01, 2010
 |  BC Extra  |  Company News

Axanum receives complete response

FDA issued a complete response letter for an NDA from AstraZeneca plc (LSE:AZN; NYSE:AZN) for Axanum aspirin/esomeprazole to reduce the risk of low-dose aspirin-associated gastric...

Read the full 109 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >